Jason J. Heavner

Jason J. Heavner

Auto-generated profile, based on publicly available information

Jason J. Heavner

University of Maryland Baltimore Washington Medical Center Glen Burnie Maryland USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
ABAshley Barlow
Ashley Barlow
KLKaitlin M. Landolf
Kaitlin M. Landolf
BBBrooke Barlow
Brooke Barlow
SYSiu Yan Amy Yeung
Siu Yan Amy Yeung
JHJason J. Heavner
Jason J. Heavner
MHMojdeh S. Heavner
Mojdeh S. Heavner

4 August 2025 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
ANAndrea Newsome
Andrea Newsome
BMBrian Murray
Brian Murray
KHKelli Henry
Kelli Henry
SSSusan E. Smith
Susan E. Smith
MBMitchell S. Buckley
Mitchell S. Buckley
ZSZachary Smith
Zachary Smith
The care of critically ill patients requires an interprofessional team. Critical care pharmacists are essential members of that interprofessional team. The purpose of these Consensus Recommendations is to present standards and guidance for individual pharmacists, institutions, and standard‐setting bodies regarding best practices for the team integration of critical care pharmacists. Twenty one individuals were invited to serve on an interprofessional expert panel. A modified Delphi approach was used to structure the consensus process for generating the consensus recommendation statements. A total of 10 consensus recommendation statements were developed along with implementation guidance, process and outcome metrics, and a future agenda for research and advocacy.

27 June 2018 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
JHJason J. Heavner
Jason J. Heavner
KAKathleen M. Akgün
Kathleen M. Akgün
MHMojdeh S. Heavner
Mojdeh S. Heavner
CEClaire C. Eng
Claire C. Eng
MDMatthew Drew
Matthew Drew
SHShyoko Honiden
Shyoko Honiden

1 September 2015 in Clinics in Chest Medicine
Verified
Journal Article
Closed access
JHJason J. Heavner
Jason J. Heavner
JSJonathan M. Siner
Jonathan M. Siner

1 July 2018 in American Journal of Critical Care
Verified
Journal Article
Closed access
PDF file
ALAudrey J. Littlefield
Audrey J. Littlefield
MHMojdeh S. Heavner
Mojdeh S. Heavner
CEClaire C. Eng
Claire C. Eng
DCDawn A. Cooper
Dawn A. Cooper
JHJason J. Heavner
Jason J. Heavner
MPMargaret A. Pisani
Margaret A. Pisani
Background Many alcohol withdrawal scoring tools are used in hospitalized patients to assess the severity of alcohol withdrawal and guide treatment. The revised Clinical Institute Withdrawal Assessment (CIWA-Ar) and the modified Minnesota Detoxification Scale (mMINDS) are commonly used but have never been correlated. Objective To determine the strength of correlation between the CIWA-Ar and mMINDS scoring tools in patients with alcohol withdrawal syndrome. Methods A single-center, prospective correlation study conducted at a large academic medical center. Patients treated for alcohol withdrawal syndrome according to the Yale Alcohol Withdrawal Protocol were identified daily, and both the CIWA-Ar and mMINDS were administered at each time point required by the protocol. Clinical data were obtained from the electronic medical records. Results A total of 185 CIWA-Ar and mMINDS scores were collected in 30 patients. The Pearson correlation coefficient across all scores was 0.82, indicating a strong correlation. The Pearson correlation coefficient was 0.87 for CIWA-Ar scores of 10 or less and 0.52 for CIWA-Ar scores above 10. Strong correlations were also shown for tremor (0.98), agitation (0.84), and orientation (0.87). Conclusions The correlation between the CIWA-Ar and mMINDS tools is strong and appears to be most robust in patients with CIWA-Ar scores of 10 or less.